Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) disclosed that its Human Capital Management and Compensation Committee granted inducement equity awards in connection with hiring a new senior leader, in line with Nasdaq Listing Rule 5635(c)(4). The company granted 1,063,830 time-based RSUs to Srinivas Attipalli, its new SVP and Head of AI & Data - Product, effective July 24, 2026.

According to Definitive Healthcare, the award was individually negotiated, made under the company’s 2023 Inducement Plan, and is subject to an applicable award agreement. The RSUs vest 25% on June 1, 2027, with the remaining 75% vesting in equal quarterly installments of 6.25% until fully vested, contingent on continued employment.

Market reaction after AI leadership change: DH +4.99% in the Jul 28 session

+4.99%

11 alerts

+4.99% Session close to close

+2.5% Peak in 7 hr 44 min

$76.09M Market Cap

0.4x Rel. Volume

In the Jul 28 session, DH gained 4.99%, reflecting a moderate positive market reaction. Argus tracked a peak move of +2.5% during that session. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The prior Q1 2026 results event, news_id 1053806, was followed by a 3.33% 24-hour move, giving this ...

Analysis

The prior Q1 2026 results event, news_id 1053806, was followed by a 3.33% 24-hour move, giving this leadership grant a company-specific comparison point. The record adds context; vesting and equity issuance remain relevant disclosures.

Key Figures

Inducement RSUs: 1,063,830 RSUs Nasdaq rule: 5635(c)(4) Initial vesting: 25% +1 more

4 metrics

Inducement RSUs 1,063,830 RSUs Effective July 24, 2026

Nasdaq rule 5635(c)(4) Inducement award listing-rule basis

Initial vesting 25% Vests June 1, 2027, subject to continued employment

Subsequent vesting 6.25% quarterly installments Remaining RSUs vest until fully vested

Historical Context

5 past events · Latest: Jun 23 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 23	leadership appointment	Positive	-1.9%	Former DH executive appointed CCO elsewhere, focusing on restaurant operator customer success.
May 21	product enhancements	Positive	-4.6%	Expanded platform coverage, CRM integration, and AI search enhancements were announced for users.
May 07	Q1 earnings report	Negative	+3.3%	Revenue declined year over year despite adjusted income, EBITDA, and cash-flow disclosures.
Apr 23	earnings timing notice	Neutral	+2.0%	Company scheduled Q1 results release and conference call for May 7, 2026.
Feb 26	FY2025 earnings report	Negative	-8.6%	Goodwill impairments accompanied 2025 results, while EBITDA and cash-flow figures remained disclosed.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent positive announcements were followed by declines in two cases, while the two earnings reports had opposite reactions.

Key Terms

restricted stock units, inducement award, nasdaq listing rule 5635(c)(4), vesting

4 terms

restricted stock units financial

"an inducement award consisting of 1,063,830 time-based restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

inducement award financial

"the Committee granted Srinivas Attipalli of the Company"

An inducement award is a special cash or equity payment given to a new hire—often an executive or key employee—outside the company’s regular pay plans to persuade them to join. Think of it like a signing bonus that can align the new person’s goals with shareholders but also represents a cost and can reduce existing owners’ percentage of the company, so investors watch these awards for their impact on ownership and future performance.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

vesting financial

"Mr. Attipalli’s RSUs will vest as follows"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Srinivas Attipalli of the Company, Definitive Healthcare’s new SVP and Head of AI & Data - Product, an inducement award consisting of 1,063,830 time-based restricted stock units (“RSUs”), effective July 24, 2026. These awards were individually negotiated and granted as an inducement material to Mr. Attipalli’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and conditions of an applicable award agreement covering the grant.

Mr. Attipalli’s RSUs will vest as follows, subject to Mr. Attipalli’s continued employment through each such date: (i) 25% will vest on June 1, 2027; (ii) the remainder will vest in quarterly installments equal to 6.25% thereafter, until fully vested.

About Definitive Healthcare

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

Investor Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251

Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com

FAQ

What inducement equity award did Definitive Healthcare (DH) grant on July 24, 2026?

Definitive Healthcare granted 1,063,830 time-based RSUs as an inducement award to a new senior leader. According to Definitive Healthcare, the grant was made under its 2023 Inducement Plan and structured to comply with Nasdaq Listing Rule 5635(c)(4).

Who received the inducement RSUs from Definitive Healthcare (DH) in July 2026?

The inducement award was granted to Srinivas Attipalli, Definitive Healthcare’s new SVP and Head of AI & Data - Product. According to Definitive Healthcare, the grant was individually negotiated in connection with his commencement of employment with the company.

How do the 1,063,830 RSUs for DH’s new SVP vest over time?

The RSUs vest 25% on June 1, 2027, with the remaining shares vesting in 6.25% quarterly installments thereafter. According to Definitive Healthcare, vesting is conditioned on Mr. Attipalli’s continued employment through each applicable vesting date.

Why did Definitive Healthcare (DH) use Nasdaq Listing Rule 5635(c)(4) for this grant?

The grant was structured as an inducement material to the new executive’s employment, consistent with Nasdaq Listing Rule 5635(c)(4). According to Definitive Healthcare, this allows equity awards outside shareholder-approved plans specifically to attract key hires.

Is the 2026 inducement RSU award to DH’s new SVP part of a specific plan?

Yes, the inducement RSUs were granted under Definitive Healthcare’s 2023 Inducement Plan. According to Definitive Healthcare, the award is also governed by a separate award agreement detailing applicable terms and conditions.